Nanovita Collaborates With ARPA Network To Power Scalable Health Decentralized Applications With Secure, On-Chain Randomness

As part of efforts to provide a verifiable randomness solution and secure computational needs to its decentralized science platform, Nanovita, a DeSci protocol, today entered into a strategic partnership with ARPA Network, a blockchain-agnostic Layer-2 computation network. This collaboration enabled Nanovita to integrate ARPA Network’s decentralized computation infrastructure to bring an added layer of trust and reliability to its decentralized health science services.

NanoVita is a DeSci (decentralized science) protocol that utilizes nanotechnology, real-world health data, and AI biological intelligence to operate a permissionless and transparent health research network aiming to enable research and development in the field of nanoscience. Using its native token (NANA), this DeSci platform runs an open, global network where nanomaterials are used to enhance human health and performance.

NanoVita Supporting Health Applications With ARPA’s Randomness

The partnership above enabled NanoVita to leverage ARPA Network’s privacy-preserving computation infrastructure to improve AI-powered decentralized health science services on its DeSci protocol. ARPA Network is a decentralized secure computation network with expertise in enhancing the fairness, security, and privacy of blockchain networks. Its secure multi-party computation and threshold signature schemes provide on-chain projects and Web3 developers with a flexible tool to build privacy-centric applications moving across numerous blockchains.

Through the integration above, NanoVita launched ARPA’s decentralized and verifiable Random Number Generator (RNG) on its DeSci protocol, enabling its decentralized health science services to access randomness that is cryptographically secure, verifiable on-chain, and resistant to cyber-attacks and manipulation. The adoption of ARPA’s decentralized and verifiable Random Number Generator (RNG) allows NanoVita to build health decentralized applications that rely on trusted random outcomes (with unpredictability and hence resistant to tampering or manipulation), without depending on opaque centralized systems.      

Elevating Web3 User Experience

Through the collaboration, both NanoVita and ARPA Network share a wider vision for a more trustworthy, scalable, and application-ready on-chain.

Nanovita focuses on studying how advanced nanomaterials can improve human health, enhance physical recovery, and accelerate long-term health outcomes and performance. To accomplish this, its DeSci protocol combines real-world health data, AI inference models, and decentralized research frameworks to generate scientific studies (findings), which are then converted into digital assets on its blockchain, ensuring immutability and transparency of the research outcomes. On the other hand, ARPA offers a crucial randomness infrastructure that helps Web3 projects and developers to build decentralized applications with more robust fairness assurance and cryptographic integrity.

Randomness means unpredictability of outcomes, implying that no application can be predicted. Application predictability can lead to cybersecurity risks. However, since computers are fundamentally deterministic, no computer can offer 100% randomness. This is the problem that ARPA Network resolves using its decentralized and verifiable Random Number Generator (RNG) infrastructure.

For Nanovita, this partnership unlocks new opportunities for engaging and reliable health decentralized applications supported by randomness that users can trust. For ARPA, this is another important alliance that enables it to bring its decentralized and verifiable Random Number Generator (RNG) infrastructure to more blockchains and Web3 ecosystems where on-chain reliability, transparency, and fairness matter.